Published in Biochem Biophys Res Commun on November 15, 1985
Evidence for the biosynthesis of bryostatins by the bacterial symbiont "Candidatus Endobugula sertula" of the bryozoan Bugula neritina. Appl Environ Microbiol (2001) 1.94
Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci U S A (1986) 1.51
Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C. Proc Natl Acad Sci U S A (1988) 1.49
Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis. Br J Pharmacol (2000) 1.18
Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol (1990) 1.10
Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents. Br J Cancer (1992) 1.02
Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells. Br J Cancer (1991) 0.91
Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF. Leuk Res (2010) 0.87
Identification, activity, and structural studies of peptides incorporating the phorbol ester-binding domain of protein kinase C. Proc Natl Acad Sci U S A (1995) 0.87
Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action. Biochem Pharmacol (2012) 0.86
Distinct modulatory effects of bryostatin 1 and staurosporine on the biosynthesis and expression of the HIV receptor protein (CD4) by T cells. Cell Regul (1991) 0.82
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1. Br J Cancer (1994) 0.78
Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro. Biochem J (1996) 0.77
Up-regulation of p21WAF1 expression in myeloid cells is activated by the protein kinase C pathway. Br J Cancer (1997) 0.77
Total synthesis of bryostatins: the development of methodology for the atom-economic and stereoselective synthesis of the ring C subunit. Chemistry (2011) 0.76
Protein kinase C: an attractive target for cancer therapy. Cancers (Basel) (2011) 0.75
Nuclear dna amounts in angiosperms. Philos Trans R Soc Lond B Biol Sci (1976) 10.59
Antibody formation by single cells from lymph nodes and efferent lymph of sheep. J Exp Med (1966) 8.86
Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol (1971) 7.75
The Relation of Atmosphere to Biological Effects of X-Rays. Genetics (1949) 7.03
The RNA world of the nucleolus: two major families of small RNAs defined by different box elements with related functions. Cell (1996) 5.14
Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med (1998) 4.08
General practitioners' management of acute back pain: a survey of reported practice compared with clinical guidelines. BMJ (1996) 3.72
Stomach NO synthesis. Nature (1994) 3.70
Genome size and the proportion of repeated nucleotide sequence DNA in plants. Biochem Genet (1974) 3.66
Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol (1998) 3.65
Early warnings of regime shifts: a whole-ecosystem experiment. Science (2011) 3.64
Recent advances in cassava pest management. Annu Rev Entomol (1999) 3.28
Proteinase secretion and growth of Clostridium histolyticum. Biochem J (1938) 3.11
Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med (1984) 3.06
Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis (2001) 3.03
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res (1997) 2.96
Intracisternal A-particle genes as movable elements in the mouse genome. Proc Natl Acad Sci U S A (1983) 2.76
Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet (2006) 2.68
Metabolism of [14C]arachidonic acid by human platelets. Biochim Biophys Acta (1976) 2.61
Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer (1988) 2.61
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet (1997) 2.56
Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem (2000) 2.53
Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. Proc Natl Acad Sci U S A (1999) 2.53
Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med (1995) 2.50
Prostaglandin D2 inhibits the aggregation of human platelets. Thromb Res (1974) 2.35
Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Biochemistry (1989) 2.34
Serum stimulates the Na+,K+ pump in quiescent fibroblasts by increasing Na+ entry. Proc Natl Acad Sci U S A (1978) 2.29
The noneffects of contingent reinforcement for attending behavior on work accomplished. J Appl Behav Anal (1972) 2.27
The traffic of cells through tissues: a study of peripheral lymph in sheep. J Anat (1970) 2.24
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee. J Natl Cancer Inst (1993) 2.22
Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol (2001) 2.13
The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res (2000) 2.10
Mouse hematopoietic stem cells. Blood (1991) 2.07
Japanese yew poisoning of large domestic animals in the Midwest. J Am Vet Med Assoc (1977) 2.07
Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol (2001) 2.05
Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J Cell Biol (1996) 2.05
Perirenal edema and toxic nephrosis in cattle, associated with ingestion of pigweed. J Am Vet Med Assoc (1975) 2.04
The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Biochem J (1971) 2.04
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
Differentiation potential of subsets of CD4-8- thymocytes. Nature (1987) 2.00
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J Biol Chem (1991) 1.97
Compliance of pediatric and adolescent cancer patients. Cancer (1986) 1.97
Formation of prostaglandins during the aggregation of human blood platelets. J Clin Invest (1973) 1.96
Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem (1998) 1.93
The migration of cells through chronically inflamed tissues. J Pathol (1970) 1.92
Acalculous cholecystitis in Viet Nam casualties. Ann Surg (1970) 1.91
Arachidonic acid causes sudden death in rabbits. Science (1974) 1.91
Activation of suppressor T cells in human autologous mixed lymphocyte culture. J Immunol (1979) 1.90
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology (1995) 1.88
Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res (1998) 1.88
If diabetes is a public health problem, why not treat it as one? A population-based approach to chronic illness. Ann Behav Med (1999) 1.88
Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys (2000) 1.87
Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med (1976) 1.86
Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens. J Biol Chem (1997) 1.84
Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest (1977) 1.84
Reevaluation of ampicillin therapy for Hemophilus influenzae meningitis. An appraisal based on a review of cases of persistent or recurrent infection. Am J Dis Child (1971) 1.82
Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res (1999) 1.82
Equity and child-survival strategies. Bull World Health Organ (2008) 1.81
Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.79
Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma. Thorax (1998) 1.78
Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity. J Immunol Methods (2000) 1.78
Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest (1974) 1.76
The national exposure research laboratory's consolidated human activity database. J Expo Anal Environ Epidemiol (2001) 1.73
Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem Biol (2000) 1.71
Antenatal diagnosis of choledochal cyst at 15 weeks' gestation: etiologic implications and management. J Pediatr Surg (1989) 1.70
Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis (2005) 1.69
Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins (1973) 1.69
The cytochrome system of Bacillus megaterium KM. The presence and some properties of two CO-binding cytochromes. Biochim Biophys Acta (1967) 1.69
The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol (1998) 1.67
Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1. Genomics (1991) 1.67
Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice. J Immunol (1978) 1.67
Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ (2006) 1.65
Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum. J Nat Prod (1987) 1.64
Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res (1994) 1.64
Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem (1978) 1.63
Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation (2001) 1.63
Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62
Adventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene. Am J Physiol (1999) 1.62
Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial. BJOG (2006) 1.60
Formation and release of prostaglandins by platelets in response to thrombin. Br J Pharmacol (1970) 1.59
Carbodiimide-resistant membrane adenosine triphosphatase in mutants of Streptococcus faecalis. I. Studies of the mechanism of resistance. J Biol Chem (1972) 1.58
Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest (1981) 1.58
Non-surgical treatment of tendo achillis rupture. J Bone Joint Surg Am (1972) 1.57
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies. J Clin Oncol (2000) 1.57
Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts. Clin Cancer Res (1998) 1.57
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors. J Clin Oncol (1999) 1.56
Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatr Scand (2014) 1.56
Functional interaction between nucleosome assembly proteins and p300/CREB-binding protein family coactivators. Mol Cell Biol (2000) 1.55
Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem (1994) 1.55
Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity. J Gerontol A Biol Sci Med Sci (1999) 1.54
Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Mol Pharmacol (1988) 1.54
Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res (1998) 1.53
Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry (2011) 1.53
Post-translational modifications of water-soluble human lens crystallins from young adults. J Biol Chem (1994) 1.53
Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C. J Biol Chem (1988) 1.52
Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52
Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci U S A (1986) 1.51
Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature (1990) 1.50
Purification of membrane attachment and inhibitory subunits of the proton translocating adenosine triphosphatase from Escherichia coli. Biochemistry (1977) 1.49